SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 3, Issue 3, 2002, Pages 115-122

  Curti, D ^a   Rognoni, F ^a   Alimonti, D ^a   Malaspina, A ^a,b   Feletti, F ^a   Tessera, S ^a   Finotti, N ^a   Rehak, L ^a   Mazzini, L ^c   Zerbi, F ^a   Poloni, T E ^d   Ceroni, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c Clinica Lavoro Rehabilitation Ctr   (Italy)

^d NONE

Author keywords

ALS; Amino acids; L84F; Mutation; SOD1

Indexed keywords

AMINO ACID; ASPARTIC ACID; GLUTAMIC ACID; SUPEROXIDE DISMUTASE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FAMILIAL DISEASE; FAMILY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AMINO ACIDS; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; ERYTHROCYTES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; SUPEROXIDE DISMUTASE;

EID: 18744407315     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/146608202760834111     Document Type: Article

References (31)

1. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
2. Deng H-X, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science 1993; 261: 1047-1051.
3. Pramatarova A, Laganiere J, Roussel J et al. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 2001; 21: 3369-3374.
4. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 2001; 21: 82-92.
5. Gelinas S, Chapados C, Beauregard M et al. Effect of oxidative stress on stability and structure of neurofilament proteins. Biochem Cell Biol 2000; 78: 667-674.
6. Cleveland DW, Liu J. Oxidation versus aggregation - how do SOD1 mutants cause ALS? Nature Med 2000; 6: 1320-1321.
7. Trotti D, Rolfs A, Danbolt NC et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nature Neurosci 1999; 2: 427-433.
8. Rothstein JD, van Kammen M, Levey AI et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
9. Ferrarese C, Sala G, Riva R et al. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 270-272.
10. Bruijn LI, Becher MW, Lee MK et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338.
11. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 1987; 22: 575-579.
12. Perry TL, Krieger C, Hansen S, Eisen A. Amyotrophic lateral sclerosis amino acid levels in plasma and cerebrospinal fluid. Ann Neurol 1990; 28: 12-17.
13. Camu W, Billiard M, Baldy-Moulinier M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand 1993; 88: 51-55.
14. Plaitakis A, Constantakakis E, Smith J. The neuroexcitotoxic amino acid glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988; 24: 446-449.
15. Alexianu ME, Robbins E, Carswell S, Appel SH. 1-Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells. J Neurosci Res 1998; 51: 58-66.
16. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/ kainate receptor-mediated injury in vitro. J Neurosci 1996; 16: 4069-4079.
17. Curti D, Malaspina A, Facchetti G et al. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 1996; 47: 1060-1064.
18. Ceroni M, Malaspina A, Poloni TE et al. Clusterings of ALS cases in central Italy due to occurrence of the L84F SOD1 gene mutation. Neurology 1999; 53: 1064-1071.
19. Brooks BR. World Federation of Neurology Research Group on Neuromuscular Disorders. El Escorial WFN Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994; 124 (Suppl): 96-107.
20. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Annal Neurol 1987; 22: 328-333.
21. Canevari L, Vieira R, Aldegunde M, Dagani F. High-performance liquid chromatographic separation with electrochemical detection of amino acids focusing on neurochemical application. Anal Biochem 1992; 205: 137-142.
22. Flohè L, Otting F. Superoxide dismutase assay. Methods Enzymol 1984; 105: 93-100.
23. Niebroj-Dobosz I, Janik P. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). Acta Neurol Scand 1999; 100: 6-11.
24. Kornhuber ME, Kornhuber J. Cerebrospinal fluid aminoacids in amyotrophic lateral sclerosis. Ann Neurol 1992; 31: 449-450.
25. Spink DC, Martin DL. Excitatory aminoacids in amyotrophic lateral sclerosis. Ann Neurol 1991; 29: 110.
26. Plaitakis A, Smith J, Mandeli J, Yahr MD. Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet 1988; i: 1015-1018.
27. Beghi E, for The Italian ALS Study Group. Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? Neurology 1993; 43: 2466-2470.
28. Bastone A, Micheli A, Beghi E, Salmona M. The imbalance of brain large chain amino acid availability in amyotrophic lateral sclerosis patients treated with high doses of branched-chain amino acids. Neurochem Int 1995; 27: 467-472.
29. Tandan R, Bromberg MB, Forshew D et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 1996; 47: 1220-1226.
30. Marklund SL. Analysis of extracellular superoxide dismutase in tissue homogenates and extracellular fluids. Methods Enzymol 1990; 186: 260-265.
31. 9O Ala Cu/Zn-superoxide dismutase mutation. J Neurochem